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Purpose: In osteoarthritis (OA), chondrocyte metabolism changes dra-
matically. Since chondrocyte metabolism is known to differ by depth
within articular cartilage, such metabolic change with OA could differ
among cartilage zones. In this study, we investigated the characteristics
of chondrocyte metabolism in respective cartilage zones of OA cartilage.
Methods: The study was performed under the approval of the ethical
committees of the institutes. OA cartilage was obtained from macroscop-
ically intact areas of 4 knee joints with end-stage disease. The cartilage
was divided into three cartilage zones (superﬁcial, middle and deep
zones) and gene expression proﬁles were determined in the respective
zones by a custom-designed microarray that focused on chondrocyte-
related genes. For genes the expression of which was signiﬁcantly dif-
ferent among the zones, the expression was compared between OA and
control cartilage in respective zones by an analysis using laser capture
microdissection (LCM) and real-time PCR. For several genes, correlation
of expression among OA cartilage samples was investigated in speciﬁc
cartilage zones.
Results: Approximately 40% of the genes investigated were found to be
expressed at signiﬁcantly different levels across the zones. Among them,
the expression of 25 genes (12 genes for cartilage components, 8 bone-
related genes, and 5 metalloproteinase genes) was compared between
OA and control cartilage in respective zones by LCM and real-time PCR,
which conﬁrmed the validity of the microarray analysis.
The expression of 12 cartilage component genes was all enhanced in
OA cartilage compared with that in the control. For these, the level of
enhancement was considerably different among the genes (2- to 220-
fold), suggesting that the balance of their synthesis might be considerably
disturbed in OA cartilage. In contrast, for all 12 genes, the difference
of expression levels among the three zones was very similar between
the OA and control cartilage, indicating that for each gene, the increase
of expression in OA cartilage occurred at a similar level throughout the
zones.
The expression of 8 bone-related genes was most enhanced in either
the superﬁcial (COL1A2, POSTN, TNA) or deep zone (COL10A1, IBSP,
SPARC, SPP1, WNT5B) within OA cartilage. Interestingly, the former
three genes are known to be expressed by osteoblasts, while two of
the latter are characteristically expressed by hypertrophic chondrocytes.
Since the expression of those genes was mutually correlated in the super-
ﬁcial and deep zones, respectively, their expression in OA cartilage was
assumed to be induced by the phenotypic change of the chondrocytes at
those zones.
The expression of 5 proteinase genes (MMP2, MMP3, MMP11, MMP13,
ADAMTS5) was all most enhanced in the superﬁcial zone within OA
cartilage. In that zone, their expression was mutually correlated, which
might suggest the presence of a common regulatory mechanism(s) for
their expression. Among the ﬁve genes, the expression of MMP11 and
MMP13 was most enhanced in OA cartilage (up to 40-fold increase),
implying that those proteinases could be deeply involved in the pathology
of OA.
Conclusions: In OA cartilage, the metabolic activity of chondrocytes dif-
fered considerably among zones. Characteristic changes were observed
in superﬁcial and deep zones.
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Purpose: Articular cartilage degeneration is a hallmark of osteoarthri-
tis (OA). We previously identiﬁed increased expression of transforming
growth factor alpha (TGFa) and chemokine (C-C motif) ligand 2 (CCL2)
in articular cartilage from a rat model of OA. We subsequently reported
that TGFa signaling modiﬁed chondrocyte cytoskeletal organization, in-
creased catabolic and decreased anabolic gene expression and sup-
pressed Sox9. Due to other roles in chondrocytes, we hypothesized that
the effects of TGFa on chondrocytes are mediated by Rho/ROCK and
MEK/ERK signaling pathways.
Methods: Primary cultures of chondrocytes and articular osteochondral
explants were treated with pharmacological inhibitors of MEK1/2 (U0126),
ROCK (Y27632), Rho (C3), p38 MAPK (SB202190) and PI3K (LY294002)
to elucidate pathway involvement.
Results: Using G-LISA we determined that stimulation of primary
chondrocytes with TGFa activates RhoA. Reciprocally, inhibition of
RhoA/ROCK but not other signaling pathways prevents modiﬁcation of the
actin cytoskeleton in response to TGFa. Inhibition of MEK/ERK signaling
rescued suppression of anabolic gene expression by TGFa including
SOX9 mRNA and protein levels. Inhibition of MEK/ERK, Rho/ROCK,
p38 MAPK and PI3K signaling pathways differentially controlled the
induction of MMP13 and TNFa gene expression. TGFa also induced
expression of CCL2 speciﬁcally through MEK/ERK activation. In turn,
CCL2 treatment induced the expression of MMP3 and TNFa. Finally,
we assessed cartilage degradation by immunohistochemical detection
of type II collagen cleavage fragments generated by MMPs. Blockade of
RhoA/ROCK and MEK/ERK signaling pathways reduced the generation
of type II collagen cleavage fragments in response to TGFa stimulation.
Conclusions: In conclusion, Rho/ROCK signaling mediates TGFa-
induced changes in chondrocyte morphology, while MEK/ERK signaling
mediates the suppression of Sox9 and its target genes, and CCL2
expression. CCL2, in turn, induces the expression of MMP3 and TNFa,
two potent catabolic factors known to be involved in OA. These pathways
may represent strategic targets for interventional approaches to treating
cartilage degeneration in osteoarthritis.
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Purpose: One of the major cytoskeletal architectures in chondrocytes is
the tubulin microtubules. Tubulin is essential for many fundamental cellu-
lar processes including mitosis and protein secretion. In chondrocytes, an
intact tubulin network has previously been shown to be required for secre-
tion of collagen and sulphated glycosaminoglycans (sGAG). Interestingly,
the spatial organisation of these networks has been observed to be
disrupted in human osteoarthritic chondrocytes or absent in a rat model
of osteoarthrosis. Therefore the aim of this study was to characterise the
effect of tubulin microtubule disassembly on articular chondrocyte matrix
synthesis and elucidate the mechanism(s) involved in this differential
regulation.
Methods: Chondrocytes from 7-day-old bovine articular cartilage were
plated at 1×106cells/well of a 24-well plate. Tubulin microtubules were
disrupted with 1mM colchicine over a 1, 3 or 7 day period, and dis-
assembly conﬁrmed by confocal microscopy. The effect of microtubule
disruption on de novo collagen and sGAG synthesis was measured by
incubating chondrocytes with 1 mM colchicine for 7 days in the pres-
ence of 20 mCi/ml [3H]-proline and 10 mCi/ml [35S]-sulphate; untreated
cultures served as controls. Unincorporated label was removed and
counts performed. Expression levels of b-tubulin and type II collagen
mRNA and protein were assessed by quantitative PCR and Western
blotting respectively. Expression and activation of TGFb1 was assessed
using an ELISA. Chondrocytes were subsequently pretreated with 1mM
colchicine for an hour prior to the addition of 10 ng/ml TGFb1 for 1, 3
or 7 days, and both Western blotting and quantitative PCR performed
to determine expression levels of type II collagen, TGFb1 and TGFb1
receptor. Downstream signalling effects i.e. activation of the MAP kinases
was monitored in tubulin-disrupted chondrocytes, in the presence or
absence of TGFb1. Restoration of matrix production was assessed by
pre-treating chondrocytes with selective MAPK inhibitors prior to addition
of colchicine.
Results: Disruption of the chondrocyte tubulin networks with 1mM
colchicine not only affected spatial organisation but also signiﬁcantly
inhibited the expression of both b-tubulin mRNA and protein over the
7 day culture period. De novo collagen and sGAG synthesis were
inhibited by tubulin disruption (stabilisation of the networks with 1mM
taxol enhanced the chondrocytic phenotype). In the absence of intact
tubulin networks, there was a signiﬁcant reduction in TGFb1. TGFb1 is a
